Literature DB >> 7735296

Negative feedback regulation following administration of chronic exogenous corticosterone.

E A Young1, S P Kwak, J Kottak.   

Abstract

Administration of exogenous glucocorticoids is known to suppress the HPA axis and has been reported to occupy brain glucocorticoid receptors, eventually leading to down-regulation. To determine the effects of chronic corticosterone administration on HPA axis function, corticosterone was administered as both 25% and 50% corticosterone/cholesterol pellets. Rats were sacrificed 6 days after corticosterone pellet implantation. The 25% corticosterone pellets produced a small increase in morning corticosterone concentrations but no change in evening ACTH or corticosterone secretion. The 50% corticosterone pellets produced constant corticosterone concentrations of 5-6 micrograms/dl, with no circadian variation in corticosterone, indicating inhibition of evening ACTH and corticosterone secretion. The 25% corticosterone pellets produced no significant decrease in thymus weight or in adrenal weight; 50% corticosterone pellets produced significant decreases in thymus weight and adrenal weight. Neither 25% nor 50% corticosterone pellets produced significant decreases in GR in hippocampus and cortex. The 50% corticosterone pellets treatment resulted in a decrease in anterior pituitary POMC mRNA levels, a decrease in baseline and oCRH stimulated ACTH release from the anterior pituitary, and a near complete inhibition of the AM and PM response to restraint stress. These results suggest that: 1) the HPA axis was able to adjust to the small increase in glucocorticoids produced by the 25% cort pellets with minimal disturbances in function and 2) 50% corticosterone pellets exert a significant inhibitory effect on stress and diurnal ACTH secretion which appears to be exerted at the pituitary as well as possible inhibitory effects on brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735296     DOI: 10.1111/j.1365-2826.1995.tb00665.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

1.  Role of glucocorticoids in tuning hindbrain stress integration.

Authors:  Rong Zhang; Ryan Jankord; Jonathan N Flak; Matia B Solomon; David A D'Alessio; James P Herman
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

2.  Developmental corticosterone treatment does not program immune responses in zebra finches (Taeniopygia guttata).

Authors:  Jennifer L Grindstaff; Loren Merrill
Journal:  J Exp Zool A Ecol Integr Physiol       Date:  2017-06

3.  Chronic stress and obesity: a new view of "comfort food".

Authors:  Mary F Dallman; Norman Pecoraro; Susan F Akana; Susanne E La Fleur; Francisca Gomez; Hani Houshyar; M E Bell; Seema Bhatnagar; Kevin D Laugero; Sotara Manalo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

4.  Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment.

Authors:  Ammar Kutiyanawalla; Alvin V Terry; Anilkumar Pillai
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

5.  Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex.

Authors:  Kristy R Howell; Ammar Kutiyanawalla; Anilkumar Pillai
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

6.  Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female mice.

Authors:  Maaike Schilperoort; Jan Kroon; Sander Kooijman; Annelies E Smit; Max Gentenaar; Kathrin Mletzko; Felix N Schmidt; Leo van Ruijven; Björn Busse; Alberto M Pereira; Natasha M Appelman-Dijkstra; Nathalie Bravenboer; Patrick C N Rensen; Onno C Meijer; Elizabeth M Winter
Journal:  Aging Cell       Date:  2021-09-30       Impact factor: 9.304

Review 7.  Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

Authors:  Xin He; James W Findling; Richard J Auchus
Journal:  Pituitary       Date:  2022-04-26       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.